Norges Bank’s Clovis Oncology, Inc. CLVS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-313,167
| Closed | -$3.27M | – | 2091 |
|
2019
Q4 | $3.27M | Buy |
313,167
+18,324
| +6% | +$191K | ﹤0.01% | 1944 |
|
2019
Q3 | $1.16M | Sell |
294,843
-170,132
| -37% | -$668K | ﹤0.01% | 2026 |
|
2019
Q2 | $6.92M | Hold |
464,975
| – | – | ﹤0.01% | 1892 |
|
2019
Q1 | $11.5M | Hold |
464,975
| – | – | ﹤0.01% | 1755 |
|
2018
Q4 | $8.35M | Hold |
464,975
| – | – | ﹤0.01% | 1802 |
|
2018
Q3 | $13.7M | Hold |
464,975
| – | – | ﹤0.01% | 1713 |
|
2018
Q2 | $21.1M | Hold |
464,975
| – | – | 0.01% | 1481 |
|
2018
Q1 | $24.6M | Sell |
464,975
-30,681
| -6% | -$1.62M | 0.01% | 1295 |
|
2017
Q4 | $33.7M | Buy |
495,656
+27,677
| +6% | +$1.88M | 0.01% | 1083 |
|
2017
Q3 | $38.6M | Sell |
467,979
-37,503
| -7% | -$3.09M | 0.01% | 959 |
|
2017
Q2 | $47.3M | Buy |
505,482
+63,628
| +14% | +$5.96M | 0.02% | 773 |
|
2017
Q1 | $28.1M | Buy |
441,854
+145,709
| +49% | +$9.28M | 0.01% | 1144 |
|
2016
Q4 | $13.2M | Buy |
296,145
+24,600
| +9% | +$1.09M | 0.01% | 1568 |
|
2016
Q3 | $9.35M | Buy |
271,545
+48,972
| +22% | +$1.69M | ﹤0.01% | 1687 |
|
2016
Q2 | $3.05M | Hold |
222,573
| – | – | ﹤0.01% | 1955 |
|
2016
Q1 | $4.27M | Hold |
222,573
| – | – | ﹤0.01% | 1886 |
|
2015
Q4 | $7.79M | Hold |
222,573
| – | – | ﹤0.01% | 1723 |
|
2015
Q3 | $20.5M | Buy |
222,573
+50,910
| +30% | +$4.68M | 0.01% | 1117 |
|
2015
Q2 | $15.1M | Hold |
171,663
| – | – | 0.01% | 1376 |
|
2015
Q1 | $12.7M | Buy |
171,663
+14,802
| +9% | +$1.1M | 0.01% | 1506 |
|
2014
Q4 | $8.78M | Buy |
156,861
+49,110
| +46% | +$2.75M | ﹤0.01% | 1698 |
|
2014
Q3 | $4.89M | Sell |
107,751
-246,223
| -70% | -$11.2M | ﹤0.01% | 1929 |
|
2014
Q2 | $14.7M | Buy |
+353,974
| New | +$14.7M | ﹤0.01% | 1772 |
|